Diamyd appoints Peter Zerhouni as President
The Board of Diamyd Medical has appointed Peter Zerhouni, Acting
President of Diamyd Medical AB, as President of the Company.
Peter Zerhouni has been involved in all aspects of the Company since
2006 and he is since April 2011 Acting President and CEO of the Company.
He assumes his position as President and CEO of Diamyd Medical AB on
July 4, 2011.
Peter Zerhouni has during the years played a key role in driving the
Company's business and clinical trials forward. He has a combined
financial and biotechnology background with degrees in Biology and
Economics & Business Administration from Lund University in Sweden and
University of California at Berkeley in the USA.
For more information, please contact:
Peter Zerhouni, Acting President and CEO Diamyd Medical AB (publ.)
Phone: 46 8 661 0026
For press material, please contact:
Andreas Ericsson, Diamyd Medical AB (publ.)
press@diamyd.com (press@diamyd.com)
Phone: 46 8 661 0026
